Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 First novel anti-tuberculosis drug in 40 years.

Literature DB >> 23392485

First novel anti-tuberculosis drug in 40 years.

Randy Osborne.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2013 PMID： 23392485 DOI： 10.1038/nbt0213-89

Source DB: PubMed Journal: Nat Biotechnol ISSN： 1087-0156 Impact factor: 54.908

× No keyword cloud information.

1 in total

1. Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study.

Authors: Tracy Dalton; Peter Cegielski; Somsak Akksilp; Luis Asencios; Janice Campos Caoili; Sang-Nae Cho; Vladislav V Erokhin; Julia Ershova; Ma Tarcela Gler; Boris Y Kazennyy; Hee Jin Kim; Kai Kliiman; Ekaterina Kurbatova; Charlotte Kvasnovsky; Vaira Leimane; Martie van der Walt; Laura E Via; Grigory V Volchenkov; Martin A Yagui; Hyungseok Kang; Rattanawadee Akksilp; Wanlaya Sitti; Wanpen Wattanaamornkiet; Sofia N Andreevskaya; Larisa N Chernousova; Olga V Demikhova; Elena E Larionova; Tatyana G Smirnova; Irina A Vasilieva; Alena V Vorobyeva; Clifton E Barry; Ying Cai; Isdore C Shamputa; Jaime Bayona; Carmen Contreras; Cesar Bonilla; Oswaldo Jave; Jeannette Brand; Joey Lancaster; Ronel Odendaal; Michael P Chen; Lois Diem; Beverly Metchock; Kathrine Tan; Allison Taylor; Melanie Wolfgang; Eunjin Cho; Seok Yong Eum; Hyun Kyung Kwak; Jiim Lee; Jongseok Lee; Seonyeong Min; Irina Degtyareva; Evgenia S Nemtsova; Tatiana Khorosheva; Elena V Kyryanova; Grace Egos; Ma Therese C Perez; Thelma Tupasi; Soo Hee Hwang; Chang-ki Kim; Su Young Kim; Hee Jeong Lee; Liga Kuksa; Inga Norvaisha; Girts Skenders; Ingrida Sture; Tiina Kummik; Tatiana Kuznetsova; Tatiana Somova; Klavdia Levina; Gustavo Pariona; Gloria Yale; Carmen Suarez; Eddy Valencia; Piret Viiklepp
Journal: Lancet Date: 2012-08-30 Impact factor: 79.321

1 in total

11 in total

1. The political and ethical challenge of multi-drug resistant tuberculosis.

Authors: Chris Degeling; Christopher Mayes; Wendy Lipworth; Ian Kerridge; Ross Upshur
Journal: J Bioeth Inq Date: 2015-01-29 Impact factor: 1.352

2. Artemisia annua and Artemisia afra extracts exhibit strong bactericidal activity against Mycobacterium tuberculosis.

Authors: Maria Carla Martini; Tianbi Zhang; John T Williams; Robert B Abramovitch; Pamela J Weathers; Scarlet S Shell
Journal: J Ethnopharmacol Date: 2020-07-27 Impact factor: 4.360

3. Inhibition of mycobacterial alanine racemase activity and growth by thiadiazolidinones.

Authors: Yashang Lee; Sara Mootien; Carolyn Shoen; Michelle Destefano; Pier Cirillo; Oluwatoyin A Asojo; Kacheong R Yeung; Michel Ledizet; Michael H Cynamon; Paul A Aristoff; Raymond A Koski; Paul A Kaplan; Karen G Anthony
Journal: Biochem Pharmacol Date: 2013-05-13 Impact factor: 5.858

4. Comparative efficacy and acceptability of five anti-tubercular drugs in treatment of multidrug resistant tuberculosis: a network meta-analysis.

Authors: Huaidong Wang; Xiaotian Zhang; Yuanxiang Bai; Zipeng Duan; Yan Lin; Guoqing Wang; Fan Li
Journal: J Clin Bioinforma Date: 2015-04-28

First novel anti-tuberculosis drug in 40 years.

1. Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study.

1. The political and ethical challenge of multi-drug resistant tuberculosis.

2. Artemisia annua and Artemisia afra extracts exhibit strong bactericidal activity against Mycobacterium tuberculosis.

3. Inhibition of mycobacterial alanine racemase activity and growth by thiadiazolidinones.

4. Comparative efficacy and acceptability of five anti-tubercular drugs in treatment of multidrug resistant tuberculosis: a network meta-analysis.

5. Filtration improves the performance of a high-throughput screen for anti-mycobacterial compounds.

6. In-silico Metabolome Target Analysis Towards PanC-based Antimycobacterial Agent Discovery.

Review 7. Bedaquiline and delamanid in the treatment of multidrug-resistant tuberculosis: Promising but challenging.

8. Draft Genome Sequence of mc251, a Highly Hydrogen Peroxide-Resistant Mycobacterium smegmatis Mutant Strain.

9. Exploration of piperidinols as potential antitubercular agents.

Review 10. Exploring the potential of endophytes from medicinal plants as sources of antimycobacterial compounds.